Blog Insight from our scientific and leadership teams. Categories View all categories14C RadiolabelingAlnwickBioanalysisCandidate DevelopmentCandidate SelectionClinical Trial ManufacturingCorporate UpdatesDennis HendersonDr. Gareth JenkinsDr. Peter ScholesDr. Richard Castledine Dr. Stuart McDougallDr. Vanessa ZannDrug Development ConsultingDrug ProductDrug Product OptimizationDrug Substance to Drug ProductEarly DevelopmentFirst-in-HumanFormulation DevelopmentFreeThink ASAPprimeGamma ScintigraphyGLP-1 TherapeuticsHealthy Volunteer TrialsHelen BakerHigh Potency APIsHuman ADMEIain ShawIan NisbetICP-MSIndustry CollaborationInhalationJohn EntwistleJohn McDermottKevser SevimLate DevelopmentMartin Wing-KingMiamiMicrobiologyModeling and SimulationModified ReleaseNazim KanjiNichole CaparelliNottinghamOmer AlpOncologyOrphan DrugsOrphan RarePaige BellisPediatricsPeptidesPharmacy CompoundingPhase 1 TrialsPhiladelphiaPR&DProject ManagementQuality AssuranceRare DiseasesReadingRegulatoryScientific AchievementsScientific InnovationScintigraphySite SpotlightSolid-State CharacterizationSolubility EnhancementDrug SubstanceIntegrated ProgramsSustainability Publish Date View all time20252024202320222021202020192018 Fulltext search 11 - 15 of 16 results Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last » Contact Us Discuss your next drug programme with us today. Let's Talk Ask Our Team
